Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-19 00:00:00 ET · period of report 2021-08-17 · accession 0001708138-21-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-19 | 2021-08-17+ | REGN | COLES N ANTHONY | Dir | M - OptEx | $345.47 | +6,000 | 1,802 | New | +$2.07M |
| DM | 2021-08-19 | 2021-08-17+ | REGN | COLES N ANTHONY | Dir | S - Sale+OE | $650.00 | -6,000 | 902 | -87% | -$3.90M |
| DM | 2021-08-19 | 2021-08-17+ | REGN | COLES N ANTHONY | Dir | M - OptEx | $0.00 | -6,000 | 5,039 | -54% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-18 | M | A | 5,100 | $345.47 | 6,002 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-17 | M | A | 900 | $345.47 | 1,802 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-17 | S | D | 900 | $650.00 | 902 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-18 | S | D | 5,100 | $650.00 | 902 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-17 | M | D | 900 | $0.00 | 10,139 | D | $345.47 · — to 2027-01-27 | 900 Common Stock | (F2) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-18 | M | D | 5,100 | $0.00 | 5,039 | D | $345.47 · — to 2027-01-27 | 5,100 Common Stock | (F2) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |